Bladder cancer is a heterogeneous disease. Non–muscle-invasive bladder cancer embraces a spectrum of tumors with varying degrees of clinical behavior. Transurethral resection remains the surgical ...

TUR is both diagnostic and therapeutic, and findings or outcomes can dictate further disease management. Restaging TUR in patients with T1 tumors is an important component of management. Intravesical ...

You've been diagnosed with bladder cancer that has not invaded the muscle layer -- i.e., non-muscle invasive bladder cancer (NMIBC), also called superficial bladder cancer. Although the cure rate with ...

Nearly four in 10 women were initially told they had a UTI before later being diagnosed with bladder cancer. The post Bladder ...

Molecular Load of Pathologically Occult Metastases in Pelvic Lymph Nodes Is an Independent Prognostic Marker of Biochemical Failure After Localized Prostate Cancer Treatment Up to 50% of patients ...

When it comes to bladder cancer, it’s important to note the differences between muscle-invasive and non-muscle-invasive bladder cancer, as it can affect the staging of the cancer. The “stage” (spread) ...

Bladder cancer is cancer that forms in the cells of the bladder. People often receive a diagnosis in its early stages when healthcare professionals can treat it successfully. Share on Pinterest Xavier ...

SAN FRANCISCO—Intravesical gemcitabine may be a safe and effective treatment for superficial bladder cancer, data suggest. Australian investigators tested the treatment in a Phase II trial that ...

Some types and grades of bladder cancer spread quickly. Doctors can treat this disease in several ways. However, treatments are most effective before bladder cancer spreads. The bladder is a hollow ...

Symptoms of bladder cancer can include issues that relate to passing urine, such as blood in urine and changes in the frequency of urination. Overall, bladder cancer is more common in males than in ...